AI’s Presence and Localisation in the Global South

By Sumona Bose

January 12, 2024

The Importance of AI Presence and Localization

In recent years, there has been a surge of research focused on the socio-technical implications of AI systems in the Global North. However, the Global South has largely been overlooked in this discourse. This article aims to shed light on the importance of AI’s presence and localization in the Global South, and how it can contribute to addressing pressing social issues in the region. AI’s presence and localisation in the global south is important as it expands its access and utilization to demographics in public health.

Explainability is a key aspect of AI systems, ensuring that the decisions and recommendations made by these systems are understandable to the people who interact with them. Explainability  and development of model designs allows developers to record decision making and understand parameters. However, techniques such as feature importance and model distillation, commonly used for explaining machine learning models, are not accessible to those without specialized knowledge.

AI Localization in the Global South

To improve the understandability of AI systems, techniques such as looking at prediction accuracy, limiting the scope of decision-making, and educating AI teams can be employed. This becomes particularly important for corporate adopters of AI, who need to ensure that decisions made by their AI systems can be explained and understood.

In the field of explainable AI (XAI), popular techniques include SHAP and LIME. SHAP measures how model features contribute to individual predictions, while LIME trains surrogate models to explain the decision-making process. These techniques have been applied to various subfields of machine learning, such as computer vision and natural language processing, resulting in the development of visual explanation maps and saliency approaches. Other methods, like Anchor, explain individual predictions of classification models for text or tabular data.

While there is growing enthusiasm about the potential of AI in the Global South, research has shown that AI can also exacerbate systemic problems, including bias and discrimination. If AI systems are not made explainable and understandable to the people who will use them, they may end up causing more harm, particularly to marginalized communities.

Conclusion

Making AI systems explainable can be a pathway to making AI more useful in real-world environments and addressing pressing social issues in domains like agriculture, healthcare, and education. Understanding how different groups of people across various settings perceive model decision-making is crucial in developing XAI systems that are responsive to their needs. AI’s presence and localisation in global south increases its explainability and use in healthcare.

Reference url

Recent Posts

Novo Nordisk performance
      

Business Dynamics: How Novo Nordisk Lost GLP-1 Market Share

🚀 Understand the market dynamics of Novo Nordisk’s GLP-1 Market Share Decline.

A case of demand underestimation, supply chain strain, and competitor agility. Using systems thinking, we unpack the dynamic forces behind Eli Lilly’s surge—and what strategic levers pharma leaders must pull to stay ahead.

#SyenzaNews #PharmaStrategy #MarketDynamics #NovoNordisk #EliLilly #GLP1

Tolebrutinib MS analysis
          

Tolebrutinib MS Analysis: Evaluating Economic Impact in SPMS

💡 Can tolebrutinib reshape the treatment landscape for progressive multiple sclerosis?

A recent report from the Institute for Clinical and Economic Review reveals promising insights on tolebrutinib, demonstrating a 31% reduction in disability progression for patients with non-relapsing secondary progressive MS. Yet, mixed outcomes and potential safety concerns raise critical questions about its long-term efficacy and market access.

Explore the nuances of this groundbreaking therapy and its implications for healthcare economics.

#SyenzaNews #HealthEconomics #MarketAccess

allopurinol Marfan syndrome orphan
       

Allopurinol Designated an Orphan Drug for Marfan Syndrome

🌟 What does the EMA’s orphan drug designation for allopurinol mean for those impacted by Marfan syndrome?

This groundbreaking move highlights a significant step forward in tackling rare diseases, offering hope to patients with limited treatment options. Allopurinol, traditionally used for gout, shows promise in addressing life-threatening aortic complications associated with Marfan syndrome, thanks to its antioxidant properties.

Dive into the implications of this development for healthcare innovation, patient access, and the future of rare disease treatment!

#SyenzaNews #HealthEconomics #Innovation #MarketAccess

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.